Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 116-122, January 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Asmar, F. A.
Right arrow Articles by Amand, G. St.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Asmar, F. A.
Right arrow Articles by Amand, G. St.

Studies on the Mechanism of Inhibition of Tumor Growth by the Enzyme Glutaminase1

Farid A. El-Asmar2, David M. Greenberg and Grace St. Amand

Department of Biochemistry and the Cancer Research Institute, University of California, School of Medicine, San Francisco, California

The Gardner 6C3HED lymphosarcoma, Leukemia L-1210, and Leukemia L-1210/aza in ascites form were inhibited in in vivo experiments by a highly purified preparation of glutaminase-asparaginase from a pseudomonad. The glutamine content of tumors was measured by an enzymatic micromethod. The results showed that glutaminase-treated tumors were depleted of free glutamine. The glutamine-synthetase activity in tissues of normal mice has been compared with that of tumor cells. Tumor tissues showed lower activity of this enzyme than did normal tissues. Glycine-14C and adenine-14C incorporation studies in vivo indicated the impairment of both the de novo and the reutilization pathways of purine synthesis. Combination therapy with azaserine-enzyme and 8-azaguanine-enzyme produced an augmentation of tumor inhibition.

1 Aided by research grants from the National Cancer Institute (CA-02915, CA-03175) and the Cancer Research Funds of the University of California.

2 Prepared from a thesis submitted in partial satisfaction for the Ph.D. degree by F. A. El-Asmar to the Graduate Division (San Francisco) of the University of California, January, 1965.

Received 4/ 6/65. Revised 7/16/65.


This article has been cited by other articles:


Home page
ScienceHome page
E. M. Hersh
L-Glutaminase: Suppression of Lymphocyte Blastogenic Responses in vitro
Science, May 14, 1971; 172(3984): 736 - 738.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.